Abstract
Cannabinoids have been known to humanity for thousands of years and have benn used for religious, pharmaceutical and recreational purposes. However, it is only since 1964, when Goani and Mechoulam isolated the most psychoactive compound of cannabis sativa, Δ9-tetrahydrocannabinol, that the scientific interest for these compounds started to develop. In the early nineties, the cloning and pharmacological characterization of the brain cannabinoid receptor (CB1) by Matsuda et al. (1990) allowed researchers to begin to comprehensively investigate the physiological importance of cannabinoid receptor-mediated actions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albin, R.L., A.B. Young and Penney J.B., 1989, The functional anatomy of basal ganglia disorders, Trends Neurosc. 12: 366.
Anderson, L.A., J.J. Anderson, T.N. Chase and Walters, J.R., 1995, The cannabinoid agonists WIN 55,212-2 and CP 55, 940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rat with unilateral lesions of the nigrostriatal pathway, Brain Res. 691: 106.
Banerjee, S.P, Snyder, S.H. and Mechoulam, R., 1975, Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes, J. Pharmacol. Exp. Ther. 194: 74.
Bidaut-Russel, M., Devane, W.A. and Howlett, A.C., 1990, Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain, J.Neurochem. 55: 21.
Childers, S.R., Sexton, T. and Roy, M.B., 1994, Effects of anandamide on cannabinoid receptors in rat brain membranes, Biochem. Pharmacol. 47: 711.
Gaoni, Y., and Mechoulam, R., 1964, Isolation, structure and partialsynthesis of anactive constituent of hashish, J. Am. Chem.
Glass, M., Faull, R.L.M and M. Dragunow, M., 1993, Loss of cannabinoid receptors in the substantia nigra in Huntington’s disease, Neuroscience 56: 523.
Guastella, J., Nelson, N., Nelson, H., Czyzyk, L., Keinan, S., Miedel, M.C., Davidson, N., Lester, H.A. and B.I. Kanner, 1990, Cloning and expression of a rat brain GABA transporter, Science 249, 1303.
Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., de Costa, B.R. and Rice, K.C., 1990, Cannabinoid receptor localization in brain., Proc. Natl. Acad. Sci. U.S.A. 87: 1932.
Herkenham, M., Lynn, A.B., de Costa, B.R. and Richfield, E.K., 1991, Neuronal localization of cannabinoid receptors in the basal ganglia of the rat, Brain Res. 547: 267.
Iversen, L.L. and Neal, M.J., 1968, The uptake of [3H]-GABA by slices of rat cerebral cortex, J. Neurochem. 15: 1141.
Kirby, M.T., Hampson, R.E. and Deadwyler, S.A., 1994, Pre-and post-synaptic effects of the cannabinoid receptor agonist WIN 55, 212-2 on synaptic potential in the dentate gyms. Soci. Neurosci. Abstr. 305.11.
Maneuf, Y.P., Mitchell I.J., Crossman A.R. and Brotchie, J.M., 1994, On the role of enkephalin-GABA transmission in the GABAergic striatal efferents to the globus pallidus, Exp. Neurol. 125: 65.
Maneuf, Y.P., Crossman A.R. and J.M. Brotchie, in press, Modulation of GABAergic transmission in the globus pallidus by the synthetic cannabinoid WIN 55, 212-2, Synapse.
Martin, J.B. and Gusella, J.F., 1986, Huntington’s disease: Pathogenesis and management. New Eng. J. Med. 315: 1267.
Matsuda, L.A., Bonner, T.I. and Lolait, S.J., 1993, Localization of cannabinoid receptor mRNA in the rat brain, J. Comp. Neurol. 327: 535.
Pertwee, R.G., 1988, Psychotropic cannabinoids, Pharmacol. Ther. 36: 189.
Pertwee, R.G. and Wickens, A.P., 1991, Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids, Neuropharmacology 30: 237.
Pertwee, R.G., 1994, The evidence for the existence of cannabinoid receptors, Gen. Pharmacol. 24: 811.
Reichman, M., Nen, W. and Hokin, L.E., 1988, Δ9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices, Mol. Pharmacol. 34: 823.
Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrera. P., Soubrie, P., Breliere, J.C. and Le Fur, G., 1994, SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor, FEBS lett. 350: 240.
Scheel-Kruger, J., Magelund, G. and Olianas, M.C., 1981, Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus, in: GABA and the basal ganglia, (G. Di Chiara and G.L. Gessa, eds. Raven Press, New York) p. 165.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Maneuf, Y.P., Brotchie, J.M. (1996). Cannabinoid Receptor-Mediated Modulation of Gabaergic Transmission in the Basal Ganglia. In: Ohye, C., Kimura, M., McKenzie, J.S. (eds) The Basal Ganglia V. Advances in Behavioral Biology, vol 47. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0194-1_21
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0194-1_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0196-5
Online ISBN: 978-1-4899-0194-1
eBook Packages: Springer Book Archive